Digital Pharma: Sanofi launches diabetes blog
January 17, 2011Medical Communications, Sales and Marketing Digital Pharma blog, Sanofi-Aventis, blog, diabetes
Sanofi-Aventis has ramped up its social media efforts with the launch of a blog about diabetes for US consumers. The …
Shire says new plant will add to Replagal, Vpriv capacity
January 17, 2011Manufacturing and Production Cerezyme, Replagal, Shire, Vpriv
UK drugmaker Shire has completed construction of a new manufacturing facility for its orphan disease drugs Replagal and Vpriv, and …
Roche finance chief steps down
January 17, 2011Sales and Marketing Alan Hippe, Erich Hunziker, Roche, appointment, sales and marketing
Roche’s chief financial officer Erich Hunziker is to retire at the end of March after ten years with the company. …
Diabetes drugs show promise in Alzheimer’s
January 17, 2011Research and Development Alzheimer's, Alzheimer’s, Byetta, Novo Nordisk, Victoza, diabetes, exenatide, lilly, liraglutide
Research suggests that new diabetes drugs enhance cell growth in the brain, and could help treat Alzheimer’s disease. Researchers at …
Digital Pharma: NHS thrombosis e-learning
January 14, 2011Medical Communications Bayer, Boehringer Ingelheim, Digital Pharma blog, NHS training, Pfizer, Sanofi-Aventis, VTE, e-learning, venous thromboembolism
The NHS has launched a best-practice website to help educate healthcare professionals about one of the most common causes of …
Gates Foundation funds TB drug discovery
January 14, 2011Research and Development Bill and Melinda Gates Foundation, IDRI, Infectious Disease Research Institute, Lilly TB Drug Discovery Initiative, TB, lilly, tuberculosis
Research to identify leads and drug targets for new tuberculosis treatments is to be funded by the Bill and Melinda …
GSK moves Crohn’s disease drug into phase III
January 14, 2011Research and Development ChemoCentryx, Crohn’s disease, GSK’786, GlaxoSmithKline, Traficet-EN
GlaxoSmithKline and its partner ChemoCentryx have started late-stage trials of GSK’786 for Crohn’s disease. The initial study is a randomised, …
Publicis acquires French comms agency
January 14, 2011Medical Communications Digital District, François Sarkozy, Healthcare Consulting, In-Sync, Publicis Healthcare Consulting, Resolute Communications, Yannick Sabatin, publicis
Paris-based communications giant Publicis Groupe has bought a health comms agency set up by the brother of French president Nicolas …
Anti-cancer stem cell drug starts clinical trials
January 14, 2011Research and Development Cancer, GSK, GlaxoSmithKline, OMP-21M18, OMP-59R5, OncoMed, Stem cells, advanced solid tumour cancers
OncoMed and GSK’s novel anti cancer stem cell drug OMP-59R5 has begun clinical trials and could represent the future direction …
Red Health boosts account team
January 14, 2011Medical Communications Jo Tubbs, Nicole Tripney, appointment, medical communications, red consultancy, red health
The Red Consultancy has started the year with two new hires for its specialist health team, Red Health. Account director …
End of the line for GSK’s resveratrol
January 14, 2011Research and Development GSK, GlaxoSmithKline, SRT2104, SRT2379, SRT501, Sirtris, multiple myeloma, resveratrol
GlaxoSmithKline is halting all work on resveratrol, a compound found in red wine and thought to have life extending properties. …
Watermeadow supports charity cycle ride
January 13, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Watermeadow is the proud sponsor of a team of Burford fire fighters and their colleagues who cycled 983 miles from …
Hanne Leth Hillman joins Zealand Pharma
January 13, 2011Medical Communications Hanne Leth Hillman, Zealand Pharma, appointment, medical communications
Danish biopharmaceutical company Zealand Pharma has appointed Hanne Leth Hillman as VP of investor relations and corporate communications. She will …
Aurobindo sells Chinese API unit to Sinopharm
January 13, 2011Manufacturing and Production API, Aurobindo Pharma, China, Sinopharm Weiqida Pharmaceutical, active pharmaceutical ingredient
Indian company Aurobindo Pharma intends to sell off a loss-making active pharmaceutical ingredient unit to Sinopharm, the largest pharmaceutical company …
Learning from other healthcare models
January 13, 2011CapGemini, Kaiser Permanente, NHS, healthcare, integrated healthcare
When you need high quality healthcare that is also affordable, prevention is definitely better than cure. How can governments and …
Pfizer lung cancer drug gets ‘rolling’ fast-track status in US
January 13, 2011Sales and Marketing Cancer, NSCLC, axitinib, bosutinib, crizotinib, non-small cell lung cancer
Pfizer has initiated a ‘rolling’ submission for its new oral ALK lung cancer drug crizotinib that could see it on …
Czech reforms will cut drug spending
January 13, 2011Sales and Marketing Czech Republic, Drug pricing, drug funding, drug spending, global pricing, healthcare reforms, medicines pricing
The Czech Republic has announced a major healthcare reform plan, including plans to restrict access to high cost new medicines. …
New cancer strategy gets £750 million boost
January 13, 2011Cancer, NHS, cancer funding, cancer strategy
The government has published a new ‘Strategy for Cancer’ that seeks to increase preventive measures and improve outcomes for oncology …
Digital Pharma: Pfizer launches Dutch prescription service
January 12, 2011Medical Communications Digital Pharma blog, Holland, Pfizer, consumer healthcare, disease awareness campaigns, healthcare coaching, ilivi.nl, patient information
Pfizer has tied up with an online pharmacy to break new ground in patient services in Holland with ilivi.nl. The …
Amgen aims for oncology expansion and a wider denosumab license
January 12, 2011Research and Development AMG- 479, AMG-386, Amgen, Cancer, Pancreatic cancer, denosumab, motasenib
Amgen is seeking to increase the use of its bone drug denosumab and further its reach into the oncology market, …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
